雅虎香港 搜尋

搜尋結果

  1. 剤形名. メリスロン錠6mgの添付文書インタビューフォームなどの情報を掲載しています。 エーザイの医療関係者向け情報サイトです。 医療用医薬品を適正にご使用いただくための情報を提供しています。

  2. 2024年3月29日 · March 29, 2024. Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment Merislon ® (generic name: betahistine mesilate) and muscle relaxant Myonal ® (generic name: eperisone hydrochloride) in ...

  3. 東京都文京区小石川4-6-10. めまい・平衡障害治療剤; 総称名:メリスロン; 一般名:ベタヒスチンメシル酸塩; 販売名:メリスロン錠6mg, メリスロン錠12mg; 製造会社:エーザイ.

  4. 由於此網站的設置,我們無法提供該頁面的具體描述。

  5. Brand name. Merislon Tablets 6mg. Eisai Co., Ltd. Word. 日本語. The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy.

  6. 2022年11月7日 · November 7, 2022. Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has entered into an agreement to divest its rights for muscle relaxant Myonal ® (generic name: eperisone hydrochloride) and vertigo and equilibrium disturbance treatment Merislon ® (generic name: betahistine mesilate) in ...

  7. 2024年3月29日 · TOKYO, Mar 29, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment Merislon® (generic name: betahistine mesilate) and muscle relaxant Myonal® (generic name: eperisone hydrochloride) in Japan to Kaken Pharmaceutical Co., Ltd.

  8. 3.服用此藥期間如需服用其它藥品時,請主動告訴您的醫師或藥師。. ★★★此藥品可能引起的副作用及處理方式:. 若症狀持續數日或嚴重時,請停藥並立即就醫或與醫師連絡。. 1.可能會有腸胃不適、頭暈、頭痛、疲倦或失眠的症狀,停藥後通常這些症狀便會 ...

  9. Merislon Tablets 12mg (Betahistine Mesilate) by Eisai Co., Ltd. formed registered in Japan | synapse. Agents affecting nervous system and sensory organs. Agents affecting sensory organs. Vertigo agents. Others. Merislon Tablets 12mg. Brand. Ambient (1-30℃ in Japan) Package You can see the package image when you select the package.

  10. www.cych.org.tw › pharm › searchdrugdetail藥品詳細資訊

    藥品簡介. 本品是一個組織胺類似物。. 劑量資訊. 治療梅尼艾氏症,劑量為一天3次,每次8~16mg。. 藥物動力學. 口服後1小時達到最高血中濃度,大部分由肝臟代謝,半衰期為3.5小時。. 可能副作用. 很少有噁心、嘔吐 及發疹等過敏症狀。. 臨床用途.

  1. 其他人也搜尋了